Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Interview: building on Spiriva – Boehringer Ingelheim's Allan Hillgrove

This article was originally published in Scrip

Executive Summary

I meet Allan Hillgrove, the amiable Australian head of pharma marketing and sales at the family-owned German pharma group Boehringer Ingelheim, during the company's annual results conference. He talks enthusiastically about the company's pioneering innovations in digital health and other "beyond the pill" initiatives aimed at enhancing its offering through technology and services. These have ranged from an award-winning app for inhaler training to the Facebook social game Syrum, in which players run a virtual pharma company.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC025059

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel